Banner Publications MH200828 N141

Publications

Results found: 237

Showing results: 1 - 50

Nature genetics

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

01-06-2022
Key
American journal of human genetics

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

05-11-2020
Key
Nature communications

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

16-01-2020
Key
Breast cancer research : BCR

Prediction and clinical utility of a contralateral breast cancer risk model.

17-12-2019
Key
The American journal of surgical pathology

Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.

01-11-2019
Key
Clinical cancer research : an official journal of the American Association for Cancer Research

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study.

01-08-2018
Key
Journal of medical genetics

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.

26-09-2022
Journal of medical genetics

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.

26-09-2022
Journal of medical genetics

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.

22-09-2022
Cancer medicine

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.

20-09-2022
European journal of cancer (Oxford, England : 1990)

Incorporating progesterone receptor expression into the PREDICT breast prognostic model.

01-09-2022
Trials

Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study.

29-07-2022
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.

20-07-2022
Cancers

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.

11-07-2022
Cancers

Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.

02-07-2022
Breast cancer research and treatment

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.

01-07-2022
Journal of the National Cancer Institute

Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies.

20-06-2022
Preventive medicine

Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention.

01-06-2022
Genome medicine

Breast cancer risks associated with missense variants in breast cancer susceptibility genes.

18-05-2022
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

20-04-2022
Annals of oncology : official journal of the European Society for Medical Oncology

Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial.

01-03-2022
JAMA oncology

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

01-03-2022
Biopreservation and biobanking

Barriers and Facilitators for Implementing a National Guideline to Foster the Responsible Use of Residual Biospecimens and Data in Health Research.

01-02-2022
Breast (Edinburgh, Scotland)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.

01-02-2022
Communications biology

Rare germline copy number variants (CNVs) and breast cancer risk.

18-01-2022
International journal of epidemiology

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

06-01-2022
Breast cancer research : BCR

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

04-01-2022
Genome medicine

Germline breast cancer susceptibility genes, tumor characteristics, and survival.

02-12-2021
Journal of pathology informatics

Browser-based Data Annotation, Active Learning, and Real-Time Distribution of Artificial Intelligence Models: From Tumor Tissue Microarrays to COVID-19 Radiology.

12-11-2021
British journal of cancer

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.

01-11-2021
Scientific reports

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

05-10-2021
Breast cancer research and treatment

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.

01-10-2021
The British journal of radiology

Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas.

01-10-2021
British journal of cancer

Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

01-10-2021
Data in brief

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.

01-10-2021
NPJ breast cancer

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression.

10-09-2021
Breast cancer research and treatment

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer.

01-09-2021
European journal of cancer (Oxford, England : 1990)

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.

01-09-2021
Genetics in medicine : official journal of the American College of Medical Genetics

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

01-09-2021
Breast cancer research : BCR

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

18-08-2021
Nature

Genetic insights into biological mechanisms governing human ovarian ageing.

01-08-2021
Breast cancer research and treatment

Letter to the editor regarding: 'Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis'.

01-08-2021
Journal of the National Cancer Institute

Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.

01-07-2021
American journal of human genetics

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

01-07-2021
Cancers

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

14-05-2021
Nature communications

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

14-05-2021
NPJ breast cancer

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

12-05-2021
International journal of cancer

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.

01-05-2021
Journal of hematology & oncology

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

17-04-2021
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

01-04-2021

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.